Ketamine as a Treatment for Adolescent Major Depressive Disorder

被引：0
|
作者：
Dwyer, Jennifer [1 ]
Sanacora, Gerard [2 ]
Bloch, Michael [3 ]
机构：
[1] Yale Child Study Ctr, New Haven, CT USA
[2] Yale Univ, New Haven, CT 06520 USA
[3] Yale Univ, Sch Med, New Haven, CT 06520 USA
来源：
BIOLOGICAL PSYCHIATRY | 2017年 / 81卷 / 10期
关键词：
Ketamine; Adolescent Depression; Suicide; Antidepressant; Glutamate;
D O I：
10.1016/j.biopsych.2017.02.729
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
1002
引用
收藏
页码：S405 / S405
页数：1
相关论文
共 50 条
  • [1] KETAMINE AS A TREATMENT FOR ADOLESCENT MAJOR DEPRESSIVE DISORDER
    Dwyer, Jennifer B.
    Bloch, Michael H.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2017, 56 (10): : S176 - S176
  • [2] Ketamine in the Treatment of Major Depressive Disorder
    Luu, Brent
    Rice, Elizabeth
    Goldin, Philippe
    [J]. JNP-JOURNAL FOR NURSE PRACTITIONERS, 2020, 16 (03): : 228 - 231
  • [3] The Nucleus Accumbens and Ketamine Treatment in Major Depressive Disorder
    Chadi G Abdallah
    Andrea Jackowski
    Ramiro Salas
    Swapnil Gupta
    João R Sato
    Xiangling Mao
    Jeremy D Coplan
    Dikoma C Shungu
    Sanjay J Mathew
    [J]. Neuropsychopharmacology, 2017, 42 : 1739 - 1746
  • [4] The Nucleus Accumbens and Ketamine Treatment in Major Depressive Disorder
    Abdallah, Chadi G.
    Jackowski, Andrea
    Salas, Ramiro
    Gupta, Swapnil
    Sato, Joao R.
    Mao, Xiangling
    Coplan, Jeremy D.
    Shungu, Dikoma C.
    Mathew, Sanjay J.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2017, 42 (08) : 1739 - 1746
  • [5] Intravenous Ketamine for Treatment-Resistant Major Depressive Disorder
    Covvey, Jordan R.
    Crawford, Alexis Noble
    Lowe, Denise K.
    [J]. ANNALS OF PHARMACOTHERAPY, 2012, 46 (01) : 117 - 123
  • [6] Effect of Ketamine Treatment on Amygdala Responsivity in Major Depressive Disorder
    Loureiro, Joana
    Leaver, Amber
    Vasavada, Megha
    Kubicki, Antoni
    Joshi, Shantanu
    Njau, Stephanie
    Wade, Benjamin
    Espinoza, Randall
    Congdon, Eliza
    Narr, Katherine
    [J]. BIOLOGICAL PSYCHIATRY, 2018, 83 (09) : S291 - S291
  • [7] Escitalopram: In the treatment of major depressive disorder in adolescent patients
    Yang L.P.H.
    Scott L.J.
    [J]. Pediatric Drugs, 2010, 12 (3) : 155 - 162
  • [8] REPEATED KETAMINE TREATMENT FOR COMORBID MAJOR DEPRESSIVE DISORDER AND ALCOHOL USE DISORDER
    Yoon, G.
    Ralevski, E.
    Abdallah, C. G.
    Arias, A. J.
    Limoncelli, D.
    Newcomb, J.
    Jane, J. S.
    Sofuoglu, M.
    Krystal, J. H.
    Petrakis, I. L.
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2016, 40 : 97A - 97A
  • [9] Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder
    Rong, Carola
    Park, Caroline
    Rosenblat, Joshua D.
    Subramaniapillai, Mehala
    Zuckerman, Hannah
    Fus, Dominika
    Lee, Yena L.
    Pan, Zihang
    Brietzke, Elisa
    Mansur, Rodrigo B.
    Cha, Danielle S.
    Lui, Leanna M. W.
    McIntyre, Roger S.
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2018, 15 (04):
  • [10] NALTREXONE PLUS KETAMINE FOR THE TREATMENT OF MAJOR DEPRESSIVE DISORDER AND ALCOHOL USE DISORDER
    Yoon, G.
    Ralevski, E.
    Arias, A. J.
    Limoncelli, D.
    Newcomb, J.
    Levy, L.
    Jane, J. S.
    Krystal, J. H.
    Petrakis, I. L.
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2018, 42 : 236A - 236A
12345